Eton Pharmaceuticals Ownership | Who Owns Eton Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Eton Pharmaceuticals Ownership Summary

Eton Pharmaceuticals is owned by 31.94% institutional investors, 5.39% insiders, and 62.68% retail investors. Opaleye management is the largest institutional shareholder, holding 9.30% of ETON shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.64% of its assets in Eton Pharmaceuticals shares.

ETON Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Eton Pharmaceuticals	31.94%	5.39%	62.68%
Sector	Healthcare Stocks	47.31%	8.01%	44.69%
Industry	Biotech Stocks	45.43%	7.81%	46.75%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Opaleye management	2.40M	9.30%	$7.88M
Vanguard group	1.03M	3.99%	$3.38M
Nantahala capital management	940.73K	3.65%	$3.10M
Westside investment management	585.40K	2.27%	$1.93M
Acuitas investments	579.96K	2.25%	$1.91M
Paradigm capital management inc/ny	300.00K	1.16%	$987.00K
Blackrock	282.39K	1.10%	$929.06K
Bridgeway capital management	253.36K	0.98%	$833.56K
Parkman healthcare partners	253.20K	0.98%	$833.02K
Geode capital management	240.33K	0.93%	$790.88K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Opaleye management	2.40M	1.80%	$7.88M
Acuitas investments	579.96K	1.02%	$1.91M
Westside investment management	585.40K	0.44%	$1.93M
Aristides capital	200.00K	0.19%	$658.00K
Nantahala capital management	940.73K	0.18%	$3.10M
Parkman healthcare partners	253.20K	0.11%	$833.02K
Paradigm capital management inc/ny	300.00K	0.04%	$987.00K
Bridgeway capital management	253.36K	0.02%	$833.56K
Essex investment management	27.25K	0.02%	$89.66K
Quantum private wealth	11.50K	0.01%	$37.84K

Top Buyers

Holder	Shares	% Assets	Change
Nantahala capital management	940.73K	0.18%	940.73K
Aristides capital	200.00K	0.19%	200.00K
Thompson siegel & walmsley	127.72K	0.01%	127.72K
Parkman healthcare partners	253.20K	0.11%	54.03K
Renaissance	106.50K	0.00%	41.47K

Top Sellers

Holder	Shares	% Assets	Change
Stonepine capital management	-	-	-110.00K
Goldman sachs group	57.50K	-	-61.35K
Essex investment management	27.25K	0.02%	-51.36K
Opaleye management	2.40M	1.80%	-50.78K
Schonfeld strategic advisors	50.92K	0.00%	-45.95K

New Positions

Holder	Shares	% Assets	Change	Value
Nantahala capital management	940.73K	0.18%	940.73K	$3.10M
Aristides capital	200.00K	0.19%	200.00K	$658.00K
Thompson siegel & walmsley	127.72K	0.01%	127.72K	$420.00K
Advisor group	300.00	-	300.00	$987.00

Sold Out

Holder	Change
Lindbrook capital	-4.00
Lazard asset management	-576.00
Adar1 capital management	-1.20K
Wells fargo & company/mn	-1.43K
Truvestments capital	-1.85K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	47	4.44%	8,228,308	14.56%	31	4.09%	14	-	15	15.38%
Mar 31, 2024	45	-22.41%	7,182,688	0.34%	27	3.60%	14	-54.84%	13	30.00%
Dec 31, 2023	58	9.43%	7,158,411	3.75%	27	3.83%	31	-6.06%	10	66.67%
Sep 30, 2023	53	51.43%	6,899,800	15.45%	26	4.92%	33	135.71%	6	20.00%
Jun 30, 2023	35	-5.41%	5,976,427	2.36%	23	4.47%	14	-12.50%	5	-37.50%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	681.72K	2.64%	-
Vanguard Institutional Extnd Mkt Idx Tr	307.58K	1.19%	-
Paradigm Micro-Cap	200.00K	0.77%	-100.00K
Bridgeway Ultra-Small Company	178.76K	0.69%	-
Fidelity Extended Market Index	144.80K	0.56%	13.35K
EAM Ultra Micro Cap	128.28K	0.50%	128.28K
Wasatch Micro Cap Value	105.10K	0.41%	105.10K
Vifag 2002 SICAV	90.00K	0.35%	-
Bridgeway Ultra-Small Company Market	67.70K	0.26%	-
Pleiades Small Cap Equity A	67.20K	0.26%	67.20K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 23, 2024	Opaleye Management Inc.	-	Buy	$79.81K
Oct 08, 2024	Opaleye Management Inc.	-	Buy	$27.91K
Oct 08, 2024	Opaleye Management Inc.	-	Buy	$210.88K
Oct 07, 2024	Opaleye Management Inc.	-	Buy	$72.23K
Oct 04, 2024	Opaleye Management Inc.	-	Buy	$101.56K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	7	-
2024 Q3	4	-
2024 Q1	-	-
2023 Q1	-	-
2022 Q3	1	-

ETON Ownership FAQ

Who Owns Eton Pharmaceuticals?

Eton Pharmaceuticals shareholders are primarily institutional investors at 31.94%, followed by 5.39% insiders and 62.67% retail investors. The average institutional ownership in Eton Pharmaceuticals's industry, Biotech Stocks , is 45.43%, which Eton Pharmaceuticals falls below.

Who owns the most shares of Eton Pharmaceuticals?

Eton Pharmaceuticals’s largest shareholders are Opaleye management (2.4M shares, 9.30%), Vanguard group (1.03M shares, 3.99%), and Nantahala capital management (940.73K shares, 3.65%). Together, they hold 16.94% of Eton Pharmaceuticals’s total shares outstanding.

Does Blackrock own Eton Pharmaceuticals?

Yes, BlackRock owns 1.10% of Eton Pharmaceuticals, totaling 282.39K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 929.06K$. In the last quarter, BlackRock decreased its holdings by -563 shares, a -0.20% change.

Who is Eton Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Opaleye management is Eton Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 1.80% of its assets in 2.4M Eton Pharmaceuticals shares, valued at 7.88M$.

Who is the top mutual fund holder of Eton Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Eton Pharmaceuticals shares, with 2.64% of its total shares outstanding invested in 681.72K Eton Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools